Efficacy of 7-day and 14-day triple therapy comprising rabeprazole-amoxicillin-tetracycline for Helicobacter pylori eradication in Bhutan: A randomized controlled study

被引：0
|
作者：
Vilaichone, R. [1 ]
Ratanachu-ek, T. [2 ]
Mahachai, V. [3 ]
机构：
[1] Thammasat Univ Hosp, Dept Med, GI Unit, Bangkok, Thailand
[2] Rajavithi Hosp, Dept Surg, Bangkok, Thailand
[3] Chulalongkorn Univ Hosp, Dept Med, GI Unit, Bangkok, Thailand
来源：
HELICOBACTER | 2017年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P02.58
引用
收藏
页数：1
相关论文
共 50 条
  • [1] COMPARISON OF 7-DAY AND 14-DAY TRIPLE THERAPY FOR HELICOBACTER PYLORI ERADICATION AND CHANGE OF ERADICATION RATE
    Lee, S.
    Yang, C.
    [J]. HELICOBACTER, 2012, 17 : 103 - 103
  • [2] Changing of eradication rate between 7-day and 14-day triple therapy for Helicobacter pylori
    Lee, Si Hyung
    Kim, Kyeong Ok
    Jang, Byung Ik
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 59 - 59
  • [3] Efficacy of 7-Day and 14-Day Triple Therapy Regimens for the Eradication of Helicobacter pylori: A Comparative Study in a Cohort of Romanian Patients
    Arama, Stefan Sorin
    Tiliscan, Catalin
    Negoita, Cristina
    Croitoru, Alexandru
    Arama, Victoria
    Mihai, Carmen Marina
    Pop, Florinel
    Garg, Amit
    [J]. GASTROENTEROLOGY RESEARCH AND PRACTICE, 2016, 2016
  • [4] 5-day vs. 7-day triple therapy with rabeprazole, clarithromycin and amoxicillin for Helicobacter pylori eradication
    Isomoto, H
    Furusu, H
    Morikawa, T
    Mizuta, Y
    Nishiyama, T
    Omagari, K
    Murase, K
    Inoue, K
    Murata, I
    Kohno, S
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2000, 14 (12) : 1619 - 1623
  • [5] Helicobacter pylori eradication: A randomised comparative trial of 7-day versus 14-day triple therapy
    Sokwala, Ahmed
    Shah, Mahesh V.
    Devani, Smita
    Yonga, Gerald
    [J]. SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2012, 102 (06): : 368 - 371
  • [6] Comment on (Efficacy of 7-Day and 14-Day Triple Therapy Regimens for the Eradication of Helicobacter pylori: A Comparative Study in a Cohort of Romanian Patients)
    Abadi, Amin Talebi Bezmin
    [J]. GASTROENTEROLOGY RESEARCH AND PRACTICE, 2016, 2016
  • [7] Efficacy of 7-Day and 14-Day Bismuth-Containing Quadruple Therapy and 7-Day and 14-Day Moxifloxacin-Based Triple Therapy as Second-Line Eradication for Helicobacter pylori Infection
    Lee, Seong Tae
    Lee, Dong Ho
    Lim, Ji Hyun
    Kim, Nayoung
    Park, Young Soo
    Shin, Cheol Min
    Jo, Hyun Jin
    Song, In Sung
    [J]. GUT AND LIVER, 2015, 9 (04) : 478 - 485
  • [8] Response to: Comment on "Efficacy of 7-Day and 14-Day Triple Therapy Regimens for the Eradication of Helicobacter pylori: A Comparative Study in a Cohort of Romanian Patients"
    Ribaldone, Davide Giuseppe
    Saracco, Giorgio
    Pellicano, Rinaldo
    [J]. GASTROENTEROLOGY RESEARCH AND PRACTICE, 2016, 2016
  • [9] EFFICACY OF 7-DAY AND 10-DAY OF VAB (VONOPRAZAN, AMOXICILLIN, AND BISMUTH SUBSALICYLATE) VERSUS 14-DAY STANDARD TRIPLE THERAPY FOR FIRST-LINE HELICOBACTER PYLORI ERADICATION: A MULTICENTER RANDOMIZED CONTROLLED TRIAL
    Phetkee, Thitiwat
    Anansawat, Veerayut
    Suksamai, Anuchit
    Songserm, Sukhum
    Yongwatana, Kachonsak
    [J]. GASTROENTEROLOGY, 2023, 164 (06) : S375 - S376
  • [10] The Efficacy and Safety of 14-day Rabeprazole Plus Amoxicillin High Dose Dual Therapy by Comparing to 14-day Rabeprazole-Containing Hybrid Therapy for the Naive Helicobacter pylori Infection in Taiwan: A Randomized Controlled Trial
    Tai, Wei-Chen
    Yang, Shih-Cheng
    Yao, Chih-Chien
    Wu, Cheng-Kun
    Liu, An-Che
    Lee, Chen-Hsiang
    Kuo, Yuan-Hung
    Chuah, Seng-Kee
    Liang, Chih-Ming
    [J]. INFECTIOUS DISEASES AND THERAPY, 2023, 12 (05) : 1415 - 1427
12345